Hypertension, cardiovascular disease, and age-related macular degeneration

Archives of Ophthalmology

Volumn 118, Issue 3, 2000, Pages 351-358

  Hyman, Leslie ^a   Schachat, Andrew P ^b   He, Qimei ^a   Leske, M Cristina ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

EID: 0034102998     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.3.351     Document Type: Article

References (43)

1. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study, I: outline and major prevalence findings. Am J Epidemiol. 1977;106:17-32.
2. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325:1412-1417.
3. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
4. Kahn HA, Moorhead HB. Statistics on Blindness in the Model Reporting Area 1969-1970. Washington, DC: US Dept of Health, Education, and Welfare; 1973. DHEW publication NIH73-427.
5. Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982;100:571-573.
6. National Center for Health Statistics. Health, United States 1989. Hyattsville, Md: Public Health Service; 1990.
7. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640-1642.
8. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study, II: association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 1977;106:33-41.
9. Klein R, Klein BEK, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:1804-1812.
10. Hyman L, Lilienfeld AM, Ferris FL, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol. 1983;118:213-227.
11. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy. Arch Ophthalmol. 1998; 116:583-587.
12. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM. Factors associated with AMD: analyses of data from the first NHANES. Am J Epidemiol. 1988;128:700-710.
13. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 1992;110:1701-1708.
14. The Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993;111:104-109.
15. Seddon JM, Ajani UA, Sperduto R, et al. Dietary carotenoids, vitamins A, C and E and advanced age-related macular degeneration. JAMA. 1994;272:1413-1420.
16. West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol. 1994;112:222-227.
17. Sperduto RD, Hiller R, Seigel D. Lens opacities and senile maculopathy. Arch Ophthalmol. 1981;99:1004-1008.
18. West SK, Rosenthal FS, Bressler NM, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol. 1989;107:875-879.
19. Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health. 1989;79:765-769.
20. Klein R, Klein BEK, Wang Q, Moss SE. Is age-related maculopathy associated with cataracts? Arch Ophthalmol. 1994;112:191-196.
21. Blumenkranz MS, Russell SR, Robey MG, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology. 1986;96: 552-558.
22. Klein R, Klein BEK, Linton KLP, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol. 1993;137:190-200.
23. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA. 1996; 276:1141-1146.
24. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA. 1996;276:1147-1151.
25. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997;123:199-206.
26. Klaver CCW, Wolfs RCW, Assink JJM, et al. Genetic risk of age-related maculopathy: population-based familial aggregation study. Arch Ophthalmol. 1998; 116:1646-1651.
27. The Early Treatment Diabetic Retinopathy Study Group. Early Treatment Diabetic Retinopathy Study: Manual of Operations. Baltimore, Md: ETDRS Coordinating Center, Dept of Epidemiology and Preventive Medicine, University of Maryland School of Medicine; 1980. National Technical Information Service publication PB85 223006/AS.
28. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453-469.
29. Cummings SR, Block G, McHenry K, Paron RB. Evaluation of two food frequency methods of measuring dietary calcium intake. Am J Epidemiol. 1987; 126:796-802.
30. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire of chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31:42-48.
31. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley & Sons Inc; 1981:218.
32. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective study of disease. J Natl Cancer Inst. 1959;22:719-748.
33. Marshall RJ, Chisholm EM. Hypothesis testing in the polychotomous logistic model with an application to detecting gastrointestinal cancer. Stat Med. 1985;4:337-344.
34. Willett W. Implications of total energy intake for epidemiolopic analyses. In: MacMahon B, ed. Nutritional Epidemiology. New York, NY: Oxford University Press Inc; 1990:245-271.
35. Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol. 1986;104:216-219.
36. Delaney WV Jr, Oates RP. Senile macular degeneration: a preliminary study. Arch Ophthalmol. 1982;14:21-24.
37. Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol. 1979;11:1197-1201.
38. Blumenkranz MS, Russell SR, Robey MC, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology. 1986;93: 552-558.
39. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study. Am J Epidemiol. 1995; 142:404-409.
40. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1990;108:816-824.
41. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BEK, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol. 1995;113:743-748.
42. Kelsey JK, O'Brien LA, Grisso JA, Hoffman S. Issues in carrying out epidemiologic research in the elderly. Am J Epidemiol. 1989;130:857-866.
43. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults: the SEE Project. Invest Ophthalmol Vis Sci. 1997; 38:72-82.